Want to see JP:4894 full AI Analyst Report?

Cuorips Inc. (4894) Price & Analysis

1 Followers

4894 Stock Chart & Stats

¥6230.00

¥25.00(0.51%)

At close: Jan 08 4:00 PM EST

¥6230.00

¥25.00(0.51%)

Day’s Range― - ―

52-Week Range¥3,610.00 - ¥12,400.00

Previous CloseN/A

Volume173.60K

Average Volume (3M)96.65K

Market Cap

¥43.45B

Enterprise Value¥32.41K

Total Cash (Recent Filing)¥3.90B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)―

Beta1.18

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-124.55

Shares Outstanding8,276,716

10 Day Avg. Volume69,530

30 Day Avg. Volume96,653

Financial Highlights & Ratios

PEG Ratio-1.03

Price to Book (P/B)12.12

Price to Sales (P/S)271.07

P/FCF Ratio-52.19

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Zero DebtA debt-free capital structure limits interest obligations and refinancing risk. This gives Cuorips greater flexibility to fund research, operations, and commercialization efforts without the additional pressure of debt servicing.

Equity CushionSubstantial equity relative to assets provides a financial cushion while the company invests and absorbs operating losses. This supports solvency over the medium term, although continued losses could gradually reduce that protection.

Historical Revenue ExpansionRevenue expansion over several years indicates the business has demonstrated some ability to build commercial activity from a small base. Sustaining that trajectory would improve operating leverage, though the latest annual decline shows execution remains uneven.

Bears Say

Revenue DeclineThe latest revenue contraction weakens evidence of product adoption and commercial traction. If the decline persists, Cuorips may struggle to spread fixed costs across sales and could require additional funding before reaching sustainable scale.

Widening LossesDeepening losses and deteriorating margins indicate that current operations are not yet economically self-sustaining. Continued losses can erode the equity cushion and increase reliance on future financing, partnerships, or successful commercialization.

Persistent Cash BurnWorsening negative free cash flow shows that cash spending remains substantial and is increasing rather than moving toward breakeven. This creates ongoing funding needs and may constrain investment capacity if losses and development costs persist.

4894 FAQ

What was Cuorips Inc.’s price range in the past 12 months?

Cuorips Inc. lowest stock price was ¥3610.00 and its highest was ¥12400.00 in the past 12 months.

What is Cuorips Inc.’s market cap?

Cuorips Inc.’s market cap is ¥43.45B.

When is Cuorips Inc.’s upcoming earnings report date?

Cuorips Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 58 days.

How were Cuorips Inc.’s earnings last quarter?

Cuorips Inc. released its earnings results on Aug 13, 2026. The company reported -¥38.48 earnings per share for the quarter.

Is Cuorips Inc. overvalued?

According to Wall Street analysts Cuorips Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cuorips Inc. pay dividends?

Cuorips Inc. does not currently pay dividends.

What is Cuorips Inc.’s EPS estimate?

Cuorips Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cuorips Inc. have?

Cuorips Inc. has 8,276,716 shares outstanding.

What happened to Cuorips Inc.’s price movement after its last earnings report?

Cuorips Inc. reported an EPS of -¥38.48 in its last earnings report. Following the earnings report the stock price went up 1.931%.

Which hedge fund is a major shareholder of Cuorips Inc.?

Currently, no hedge funds are holding shares in JP:4894

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cuorips Inc.

Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.